BridgeBio Pharma, Inc. (BBIO)
$65.35+0.48%Close
SELLRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $12.8B
- Beta
- 0.97
- P/E (TTM)
- -18.70
- Short % float
- 11.63%
- Days to cover
- 5.8
- SI change
- -8.7%
- 1W
- -2.83%
- 1M
- -9.86%
- vs SPY 1W
- -3.99%
- vs SPY 1M
- -12.85%
Industry peers
FMP comparable companies · ranked by market cap
- ALNYSELLAlnylam Pharmaceuticals, Inc.$30.0BRECOVERYQ 28$224.41+3.63%
- ASNDSELLAscendis Pharma A/S$14.2BRECOVERYQ 35$228.41+2.94%
- BMRNSELLBioMarin Pharmaceutical Inc.$10.7BBEARQ 12$55.20-0.16%
- IONSSELLIonis Pharmaceuticals, Inc.$7.3BRECOVERYQ 8$44.16+4.57%
- PTCTSELLPTC Therapeutics, Inc.$5.3BRECOVERYQ 18$63.23+3.42%
- SRRKSELLScholar Rock Holding Corporation$5.1BCRISISQ 22$42.20-0.02%
- TVTXSELLTravere Therapeutics, Inc.$5.0BCRISISQ 33$53.44+0.17%
- DNLISELLDenali Therapeutics Inc.$3.0BCRISISQ 8$19.16+4.18%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$14.89+1.24%
- MAZEBUYMaze Therapeutics, Inc.$1.5BRECOVERYQ 35$26.25+4.75%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
